Jeffrey R. Baxter
2022
In 2022, Jeffrey R. Baxter earned a total compensation of $1.8M as President, Chief Executive Officer at VBI Vaccines, a 47% decrease compared to previous year.
Compensation breakdown
| Bonus | $162,624 |
|---|---|
| Option Awards | $922,377 |
| Salary | $677,600 |
| Other | $67,835 |
| Total | $1,830,436 |
Baxter received $922.4K in option awards, accounting for 50% of the total pay in 2022.
Baxter also received $162.6K in bonus, $677.6K in salary and $67.8K in other compensation.
Rankings
In 2022, Jeffrey R. Baxter's compensation ranked 1,894th out of 5,672 executives tracked by ExecPay. In other words, Baxter earned more than 66.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,894 out of 5,672 | 67th |
Division Manufacturing | 999 out of 3,081 | 68th |
Major group Chemicals And Allied Products | 417 out of 1,396 | 70th |
Industry group Drugs | 382 out of 1,297 | 71st |
Industry Pharmaceutical Preparations | 272 out of 940 | 71st |
Source: SEC filing on May 1, 2023.
Baxter's colleagues
We found two more compensation records of executives who worked with Jeffrey R. Baxter at VBI Vaccines in 2022.
News
VBI Vaccines CEO Jeffrey Baxter's 2023 pay falls 51% to $894K
April 29, 2024
VBI Vaccines CEO Jeffrey Baxter's 2022 pay falls 47% to $1.8M
May 1, 2023
VBI Vaccines CEO Jeffrey Baxter's 2021 pay jumps 54% to $3.5M
April 29, 2022
VBI Vaccines CEO Jeffrey Baxter's 2020 pay jumps 63% to $2.2M
April 26, 2021
VBI Vaccines CEO Jeffrey Baxter's 2019 pay slips 8% to $1.4M
April 28, 2020
VBI Vaccines CEO Jeffrey Baxter's 2018 pay jumps 81% to $1.5M
April 29, 2019